Clinical Trials Directory

Trials / Unknown

UnknownNCT05423821

Non-operating Room Anesthesia Experiences in Pediatric Magnetic Resonance Imaging Cases

Out Patient Anesthesia Experiences in Pediatric Magnetic Resonance Imaging Cases

Status
Unknown
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Yunus Emre · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Accepted

Summary

In recent years, out patient anesthesia applications have been increasing for diagnostic and interventional procedures for pediatric patients. In this study, we aimed to retrospectively analyze the anesthesia applications performed in pediatric MRI cases in our hospital. It is a retrospective study

Detailed description

In recent years, applications with sedation and/or general anesthesia for diagnostic purposes in pediatric cases with Magnetic Resonance Imaging (MRI) method have been increasing. Although imaging methods are useful in diagnosis and treatment, they carry minimal risk for patients. As the demands for anesthesia increase during Magnetic Resonance Imaging, questions have arisen about what can be done safely in anesthesia management. The type of anesthesia applied for Magnetic Resonance Imaging is called non-operating room anesthesia. Cross-sectional imaging techniques such as MRI require pediatric patients to remain calm for up to one hour, and thus these patients need anesthesia. In the induction of anesthesia with agents used in anesthesia outside the operating room, the patient sleeps quickly, the vital functions are stable in its maintenance, the patient recovers quickly after anesthesia, the physical and mental activities return to normal as soon as possible after recovery, and there are no side effects such as nausea, vomiting, dizziness and pain that will delay the discharge. is necessary. Sedation or general anesthesia carries risks and can have unintended consequences if poorly managed.

Conditions

Interventions

TypeNameDescription
OTHERAnesthesia efficacy in patients undergoing MRIatropine will be administered when bradycardia develops, oxygen will be given if hypoxia develops

Timeline

Start date
2022-06-14
Primary completion
2022-07-15
Completion
2022-07-25
First posted
2022-06-21
Last updated
2022-06-21

Source: ClinicalTrials.gov record NCT05423821. Inclusion in this directory is not an endorsement.